Keyphrases
Vascular Endothelial Growth Factor
100%
Tumor Metastasis
100%
Matrix metalloproteinase-9 (MMP-9)
100%
E-type
100%
Prostaglandin E
100%
EP3 Receptor
66%
WT Mice
50%
Endothelial Cells
33%
Lung
33%
Tumor Angiogenesis
33%
NS-398
33%
Tumor Growth
16%
Receptor Signaling
16%
Non-selective
16%
Human Umbilical Vein Endothelial Cells (HUVECs)
16%
Cyclooxygenase Inhibitors
16%
Receptor Antagonist
16%
Immunohistochemical Study
16%
Cyclooxygenase-2
16%
Cyclooxygenase-1 (COX-1)
16%
Receptor Knockout
16%
Lung Metastasis
16%
Aspirin
16%
Prostaglandin E2
16%
Prostaglandin E2 Receptor
16%
Lewis Lung Carcinoma
16%
Lewis Lung Carcinoma Cells
16%
Cyclooxygenase-2 Inhibitors
16%
SC-560
16%
Enhanced Matrix
16%
EP 3
16%
Cancer Prognosis
16%
Medicine and Dentistry
Vasculotropin
100%
Receptor
100%
Upregulation
100%
Metastatic Carcinoma
100%
Prostaglandin E
100%
Gelatinase B
100%
Endothelial Cell
33%
Vasculotropin A
33%
Angiogenesis
33%
Lung
33%
Neoplasm
16%
Lung Metastasis
16%
Receptor Antagonist
16%
Tumor Progression
16%
Acetylsalicylic Acid
16%
Prostaglandin E Receptor
16%
Lewis Lung Carcinoma Cell
16%
Cyclooxygenase 2
16%
Cyclooxygenase 2 Inhibitor
16%
Prostaglandin E2
16%
Lewis Lung Carcinoma
16%
Cancer Prognosis
16%
5 (4 Chlorophenyl) 1 (4 Methoxyphenyl) 3 Trifluoromethyl 1h Pyrazole
16%
Cyclooxygenase 1 Inhibitor
16%
Prostaglandin Synthase Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Receptor
100%
Gelatinase B
100%
Prostaglandin E
100%
Wild Type Mouse
50%
Lewis Carcinoma
33%
Vasculotropin A
33%
NS-398
33%
Tumor Growth
16%
Neoplasm
16%
Prostaglandin Synthase Inhibitor
16%
Receptor Antagonist
16%
Lung Metastasis
16%
Acetylsalicylic Acid
16%
COX-2 Inhibitor
16%
Prostaglandin E2
16%
Prostaglandin E Receptor
16%
Cyclooxygenase 2
16%
5 (4 Chlorophenyl) 1 (4 Methoxyphenyl) 3 Trifluoromethyl 1h Pyrazole
16%
Cyclooxygenase 1 Inhibitor
16%
Cancer Prognosis
16%